SELANK (10 mg) - peptide with nootropic and anxiolytic properties
10 mg, lyophilizate
Please verify the availability of the product in stock before proceeding with the order.
SELANK is a peptide with nootropic and anxiolytic properties. Selank improves memory and learning ability, has pronounced soothing properties and has a beneficial effect on pain perception. It is a short, synthetic analogue of the naturally occurring immunomodulatory peptide tuftsin.
Selank, a registered and marketed drug, is a regulatory nonapeptide characterized by nootropic effects, and is a synthetic derivative of Tuftsin. Selank was created by researchers from the Institute of Molecular Genetics of the Russian Academy of Sciences. The drug is characterized by combined effects: anti-anxiety (anxiolytic) action is combined with the activation of cognitive function, as well as memory work.
Selank in the study proved to be a long-acting psychostimulant with immunotropic activity. The peptide reduced the level of behavioral disorders in experimental animals, and also reduced the time of the immobilization period.
Selank has shown itself positively in the treatment of essential tremor. As a result of clinical studies, patients showed good dynamics, responded more adequately to the environment, improved indicators of dynamic praxis. Also, Selank helped to improve the adaptation of patients to everyday life. In patients with parkinsonism, a decrease in fatigue and tremor was shown, in general, a positive trend was observed, which persisted after the completion of the course of taking the drug.
Experiments on monkeys with interhemispheric asymmetry of the brain, neurotic symptoms, and impaired cognitive processes against the background of anxiety states showed that intranasal administration of 30 to 100 µg/kg of Selank has a cerebroprotective effect, reduces anxiety, and also improves memory.
Selank solution, when used intranasally, has a positive effect on libido and stimulates sexual function, which has been shown in female volunteers. The effect occurred within 10 days, the aversion to sexual intercourse disappeared, the episodes of orgasm onset became more frequent, but hypersexuality was not observed.
The immunotropic activity of Selank was manifested in an increase of up to ~20% in the phagocytic activity of macrophages without toxic effects. In vitro, Selank exhibits cytokine and interferon inducing properties that can activate immunity. Selank with a concentration demonstrates antiviral effects in vitro and in vivo with an efficiency close to ridostin, an interferon inducer, against influenza viruses (H3N2 strain) and type 2 herpes.
Selank has been clinically tested as a potential treatment for generalized anxiety disorder.
Quantity: 10 mg
Purity: over 97%
Form: lyophilizate
Excipient: mannitol
Storage: no more than +5C
Amino acid sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular weight: 751.9
Molecular formula: C33H57N11O9
Synonyms: Selanc, Селанк, TKPRPGP
Main area of research: brain function
Structural formula:
By purchasing Russian Peptide product samples from this site, you understand that they are for research purposes only and not for the treatment of humans or animals.
Method of application:
The products are for professional use only. Peptide products are intended for research and scientific purposes only.
Guaranteed authenticity and quality:
100% original product from RUSSIAN PEPTIDE (Russian Federation)
RUSSIAN PEPTIDE is a commercial, innovative technology-based organization providing a full range of services to the pharmaceutical, biotechnology and cosmetics industries.
The company specializes in the development of technology and production of peptides and complex organic molecules as biologically active ingredients and their intermediates, biochemical substances for in vitro research purposes, reference standards for the calibration of analytical equipment, as well as reagents for peptide synthesis.
Development and production:
RUSSIAN PEPTIDE is a commercial, innovative technology-based organization providing a full range of services to the pharmaceutical, biotechnology and cosmetics industries.
